PRMT7 and chronic obstructive pulmonary disease: There was a significant increase in PRMT7 mRNA expression in COPD global initiative for chronic obstructive lung disease (GOLD) stage III-IV patients, compared to never-smokers, ex-smokers without COPD, and ex-smokers with COPD GOLD II (Supplementary Fig. 2c).